Froimson Mark
CIK 0001709050
Director
Filings
7
Latest Mar 19, 2026
Issuers covered
1
Showing
7 of 7
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | -0.9% | +0.2% | +5.8% | -8.8% |
| 90 days | 2 | 100% | +22.0% | +22.0% | +42.4% | +1.7% |
| 180 days | 2 | 100% | +63.9% | +63.9% | +112.4% | +15.4% |
| 365 days | 2 | 100% | +65.1% | +65.1% | +101.9% | +28.3% |
Issuers
Companies where Froimson Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PCRX | Pacira Biosciences, Inc. | 7 | Mar 19, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|